Sahara International Petrochemical Company (2310) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Demonstrated resilience with a strong balance sheet and positive financial indicators despite challenging market conditions.
Revenue for Q1 2025 reached SAR 1,969.8 million, up 2.3% year-over-year, with net profit at SAR 230.3 million, a 6.2% increase from Q1 2024.
Continued execution of long-term growth strategy, including new feedstock allocations and ongoing expansion projects.
Profitability was supported by a significant share of profit from equity accounted investees, offsetting lower operating profit due to higher costs and a SAR 200 million asset impairment.
The Group's performance was impacted by lower selling prices and higher feedstock costs, but management expects improvement in the next twelve months.
Financial highlights
Q1 2025 revenue reached SAR 1,969.8 million, with EBITDA at SAR 375.5 million (19.1% margin), and net income at SAR 195.3 million.
Net profit for Q1 2025 was SAR 230.3 million, up 6.2% year-over-year, aided by a SAR 429 million gain from TSOC loan restructuring.
Free cash flow stood at SAR 237.4 million; gearing ratio at 0.13x.
Net income included a positive one-off from debt restructuring (SAR 429m) and a negative one-off from a SAR 200m impairment due to mothballing the EA plant.
Basic and diluted EPS for Q1 2025 were SAR 0.27, up from SAR 0.25 in Q1 2024.
Outlook and guidance
Near-term market outlook remains cautious due to global trade tensions, economic challenges, and chemical market downcycle.
Management anticipates a recovery in product selling prices and improved performance over the next twelve months.
Management is focused on cost optimization, operational excellence, and agile marketing to maintain competitiveness.
Latest events from Sahara International Petrochemical Company
- Net loss and asset impairments in Q3 2025, but free cash flow and liquidity remain strong.2310
Q3 202521 Nov 2025 - Net profit plunged on impairments and cost pressures, but free cash flow and dividends held firm.2310
Q2 202511 Aug 2025 - Revenue and profit fell, but management expects a market rebound within a year.2310
Q3 202413 Jun 2025 - Net profit declined in H1 2024 as lower sales prices and higher costs pressured margins.2310
Q2 202413 Jun 2025 - Net profit fell sharply in 2024, but liquidity and dividend payouts remained robust.2310
Q4 20245 Jun 2025